CLINICAL, ANAMNESTIC, AND GENETIC CHARACTERISTICS OF PATIENTS WITH INFERTILITY AND PERITONEAL ENDOMETRIOSIS
- Authors: Dubinskaya E.1, Gasparov A.1, Fedorova T.2, Lapteva N.1, Titov D.3
-
Affiliations:
- Peoples’ Friendship University of Russia
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology
- United Hospital and Polyclinic, Department for Presidential Affairs of the Russian Federation
- Issue: Vol 25, No 1 (2014)
- Pages: 52-56
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115926
- ID: 115926
Cite item
Abstract
The authors assess the clinical and anamnestic characteristics of patients with infertility and peritoneal endometriosis versus NAT2 gene point mutations.
Full Text
About the authors
E. Dubinskaya
Peoples’ Friendship University of Russia
Email: eka-dubinskaya@yandex.ru
MD
A. Gasparov
Peoples’ Friendship University of RussiaProfessor, MD
T. Fedorova
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and PerinatologyProfessor, MD
N. Lapteva
Peoples’ Friendship University of Russia
D. Titov
United Hospital and Polyclinic, Department for Presidential Affairs of the Russian Federation
References
- Бурлев В.А., Гаспаров А. С., Дубинская Е.Д. и др. Варианты ангиогенной активности перитонеальной формы эндометриоза для оценки эффективности лечения бесплодия у женщин // Проблемы репродукции. - 2008; 2: 52-8.
- Senapati S., Barnhart K. Managing Endometriosis Associated Infertility // Clin. Obstet. Gynecol. - 2011; 54 (4): 720-6.
- Babu K., Rao K., Reddy N. et al. N-acetyl transferase 2 polymorphism and advanced stages of endometriosis in South Indian women // Reprod. Biomed. Online. - 2004; 9 (5): 533-40.
- Баранов В.С. Генетический паспорт - основа индивидуальной и предиктивной медицины.2009;260-71.
- Шевченко О.В., Бычков Е.Н., Свистунов А.А. и др. Влияние полиморфизмов гена NAT2 на метаболизм холестерола у больных артериальной гипертензией // Фунд. исслед. - 2012; 7: 219-23.
- Bray G. Definition, measurement, and classification of the syndromes of obesity // Int. J. Obes. - 1978; 2 (2): 99-112.
- Sabbagh A., Darlu P., Crouau-Roy B. et al. ArylamineN-Acetyltransferase 2 (NAT2) Genetic Diversity and Traditional Subsistence: A Worldwide Population Survey // PLoS One. - 2011; 6 (4): e18507.
- Korkina L., Scordo M., Deeva I. et al. The chemical defensive system in the pathobiology of idiopathic environment-associated diseases // Curr. Drug. Metab. - 2009; 10 (8): 914-31.
- Fernandes M., DeCarvalho D., Dos Santos A. et al. Association of Slow Acetylation Profile of NAT2 with Breast and Gastric Cancer Risk in Brazil // Anticancer. Res. - 2013; 33 (9): 3683-9.
- Cui X., Lu X., Hiura M. et al. Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population // Environ. Health Prev. Med. - 2013; 18 (2): 136-42.
- Mahasneh A., Jubaili A., El Bateiha A. et al. Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer // Genet. Mol. Biol. -2012; 35 (4): 725-33.
- Баранов В.С. Генетический паспорт - основа индивидуальной и предиктивной медицины. 2009; 260-71.
- Бочков Н.П. Клиническая генетика. 2001; 227-46.
- Garcia-Closas M., Rothman N., Figueroa J. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer // Cancer. Res. -2013; 73 (7): 2211-20.
- Баранов В.С. Генетический паспорт - основа индивидуальной и предиктивной медицины. 2009; 260-71.
- Acién P., Velasco I. Endometriosis: a disease that remains enigmatic // ISRN Obstet. Gynecol. - 2013; 2013: 242149.
- Baranova H., Canis M., Ivaschenko T. et al. Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis // Mol. Hum. Reprod. - 1999; 5 (7): 636-41.
- Fakis G., Boukouvala S., Kawamura A. Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macacamulatta), a model animal for endometriosis // Pharmacogenet. Genomics. - 2007; 17 (3): 181-8.
- Herington J., Bruner-Tran K., Lucas J. et al. Immune interactions in endometriosis // Exp. Rev. Clin. Immunol. - 2011; 7 (5): 611-26.
- Bruner-Tran K., Yeaman G., Crispens M. et al. Dioxin May Promote Inflammation-Related Development of Endometriosis // Fertil. Steril. - 2008; 89: 1287-98.
- Цвелев Ю.В. Перекисное окисление липидов в патогенезе эндометриоза яичников // Вестн. рос. ассоц. акушеров-гинекол. - 1998; 2: 26-31.
- Sun Y. Free radicals, antioxidant enzymes, and carcionogenesis // Free Radic. Biol. Med. - 1990; 8 (6): 583-99.
- Кольман Я. Наглядная биохимия. Мир. 2000: 469.
- Gregoraszczuk E., Ptak A. Endocrine-Disrupting Chemicals: Some Actions of POPs on Female Reproduction // Int. J. Endocrinol. - 2013; 2013: 828532.
- Wong E., Cheng C. Impacts of environmental toxicants on male reproductive dysfunction // Trends Pharmacol. Sci. - 2011; 32 (5): 290-9.
- Rebourcet D., Odet F., Vérot A. et al. The effects of an in utero exposure to 2,3,7,8-tetrachloro-dibenzo-p-dioxin on male reproductive function: identification of Ccl5 as a potential marker // Int. J. Androl. - 2010; 33 (2): 413-24.
- Mocarelli P., Gerthoux P., Needham L. et al. Perinatal Exposure to Low Doses of Dioxin Can Permanently Impair Human Semen Quality // Environ. Health Perspect. - 2011; 119 (5): 713-8.
- Гуньков С.В., Моисеенко Р.А., Проданчук Н.Г. Влияние органохлоринов на репродуктивную систему женщин // Соврем. пробл. токсикол. - 2009; 2: 12-28.
- Казанцева Е.В., Долгушина Н.В., Ильченко И.Н. Влияние антропогенных химических веществ на течение беременности // Акуш. и гинекол. - 2013; 2: 18-23.
- Foster W. Environmental contaminants and dietary factors in endometriosis // Ann. N. Y. Acad. Sci. - 2002; 955: 213-32.
- Rier S. Environmental dioxins and endometriosis // Semin. Reprod. Med. -2003; 21 (2): 145-54.
- Баранов В.С. Генетический паспорт - основа индивидуальной и предиктивной медицины.2009; 260-71.
- Dairou J., Petit E., Ragunathan N. et al. Arylamine N-acetyltransferase activity in bronchial epithelial cells and its inhibition by cellular oxidants // Toxicol. Appl. Pharmacol. - 2009; 236 (3): 366-71.